LOGO
LOGO

Quick Facts

Camtek Q1 Results Climb, Beat Estimates; Sees Higher Q2 Revenues; Stock Up In Pre-market

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Camtek Ltd. (CAMT), a semiconductor equipment manufacturer, reported Thursday that its first-quarter net income totaled $24.8 million or $0.51 per share, an increase of 21 percent from last year's $17.2 million or $0.36 per share.

Adjusted net income was $31.3 million or $0.64 per share, compared to $20.4 million or $0.42 per share a year ago.

Revenues for the first quarter were $97.0 million, up 34 percent from $72.5 million in the prior year.

Analysts on average expected the company to report earnings of $0.57 per share on revenues of $93.64 million, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

Looking ahead, for the second quarter, the company expects revenues between $100 million to 102 million, representing a 37 percent mid-point increase over the second quarter of 2023.

Looking beyond 2024, as AI continues to transform the industry, the company said it is very confident in its ability to capitalize on the trend and grow towards the milestone of annual sales in excess of $500 million.

In pre-market activity on the Nasdaq, Camtek shares were gaining around 3.4 percent to trade at $87.26.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19